Trials / Unknown
UnknownNCT01554345
Effect of Vitamin E+Selenium on Kidney Function in Controlled Hypotension
Assessment of Preventive Effect of Vitamin E +Selenium on Acute Kidney Injury Through NGAL in Patients Undergoing Controlled Hypotension During Neurosurgery Operations
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether Kidney injury happens in controlled hypotension during brain operations by using Neutrophil Gelatinase Associated Lipocalin ELISA Kit and if so, does VitaminE+Selenium prevent it
Detailed description
NGAL(Neutrophil Gelatinase Associated Lipocalin) is a 25KD protein which bounds with Gelatinase in Neutrophil granules.It is also expressed in epithelial cells of kidney tubules.NGAL increases in ischemic and toxic injuries of kidney. During controlled hypotension in brain operations injury to the kidneys might occur . This study is designed to assess this possibility and evaluate the effect of VitaminE+Selenium on prevention of this problem
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | vitamin E +Selenium | vitamin E 400 IU once 8 hrs before operation selenium 150 mic once 8 hrs before operation |
Timeline
- Start date
- 2011-06-01
- Primary completion
- 2012-08-01
- First posted
- 2012-03-14
- Last updated
- 2012-03-14
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01554345. Inclusion in this directory is not an endorsement.